TG THERAPEUTICS, INC. Increase (Decrease) in Restricted Cash
TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Restricted Cash of $4.08 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-15
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $1.03K, a 0.78% increase year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $1.03K, a 0.68% increase year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $1.02K, a 0.59% increase year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $1.00K, a 0.30% decline year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2017 was $4.08K, a 0.44% increase from fiscal 2016.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2016 was $4.07K, a 1.60% decline from fiscal 2015.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2015 was $4.13K, a 99.28% decline from fiscal 2014.
- TG THERAPEUTICS, INC. increase (decrease) in restricted cash for fiscal 2014 was $575.01K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.06K derived: sum of 2 quarters · filed 2018-03-15 | $3.08K derived: sum of 3 quarters · filed 2018-03-15 | $4.08K 10-K · filed 2018-03-15 |
| 2017-09-30 | $1.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.05K derived: sum of 2 quarters · filed 2017-11-09 | $3.05K 10-Q · filed 2017-11-09 | $4.08K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $1.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.02K 10-Q · filed 2017-08-09 | $3.04K derived: sum of 3 quarters · filed 2018-03-15 | $4.07K derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-10 | $2.03K derived: sum of 2 quarters · filed 2018-03-15 | $3.05K derived: sum of 3 quarters · filed 2018-03-15 | $4.06K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.05K derived: sum of 2 quarters · filed 2018-03-15 | $3.06K derived: sum of 3 quarters · filed 2018-03-15 | $4.07K 10-K · filed 2018-03-15 |
| 2016-09-30 | $1.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.03K derived: sum of 2 quarters · filed 2017-11-09 | $3.04K 10-Q · filed 2017-11-09 | $4.06K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $1.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.02K 10-Q · filed 2017-08-09 | $3.04K derived: sum of 3 quarters · filed 2018-03-15 | $4.05K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $1.01K 10-Q · filed 2017-05-10 | $2.02K derived: sum of 2 quarters · filed 2018-03-15 | $3.04K derived: sum of 3 quarters · filed 2018-03-15 | $4.08K derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $1.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.03K derived: sum of 2 quarters · filed 2018-03-15 | $3.07K derived: sum of 3 quarters · filed 2018-03-15 | $4.13K 10-K · filed 2018-03-15 |
| 2015-09-30 | $1.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.05K derived: sum of 2 quarters · filed 2016-11-09 | $3.11K 10-Q · filed 2016-11-09 | $578.13K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $1.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.10K 10-Q · filed 2016-08-09 | $577.11K derived: sum of 3 quarters · filed 2017-03-16 | $577.11K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $1.06K 10-Q · filed 2016-05-10 | $576.07K derived: sum of 2 quarters · filed 2017-03-16 | $576.07K derived: sum of 3 quarters · filed 2017-03-16 | $576.07K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $575.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $575.01K derived: sum of 2 quarters · filed 2017-03-16 | $575.01K derived: sum of 3 quarters · filed 2017-03-16 | $575.01K 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |